Genus hit by bills and weather

Animal genetics group Genus was off slightly on Thursday after it said higher feed costs and the impact of bad weather had dented profits.

Animal genetics group Genus was off slightly on Thursday after it said higher feed costs and the impact of bad weather had dented profits.

Shares dropped 2% as the firm said it believed Genus was on course to achieve another year of growth.

The company said revenues for the four months to the end of October were slightly ahead of the previous year.

But operating profits were down due to increased feed costs at the company's genetic nucleus farms and by delayed sales in Genus ABS caused by adverse weather conditions in Latin America.

Genus PIC, which includes porcine operations in North America, Latin America and Europe, recorded continued growth across all three regions.

However, Genus ABS, which covers dairy and beef businesses in North America, Latin America and Europe, had a slow start to the year, the company said.

Volumes were lower in Latin America where adverse weather conditions in Argentina and Brazil caused a delay in semen sales.

Shares in the firm were down 2% at 9.30am on Thursday following the announcement.

Recommended

Share tips of the week – 19 August
Share tips

Share tips of the week – 19 August

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
19 Aug 2022
How to invest in smart factories as the “fourth industrial revolution” arrives
Share tips

How to invest in smart factories as the “fourth industrial revolution” arrives

Exciting new technologies and trends are coming together to change the face of manufacturing. Matthew Partridge looks at the companies that will drive…
18 Aug 2022
How to invest today? Look to the past, not the future
Investment strategy

How to invest today? Look to the past, not the future

The past few years have seen so many changes to our way of life that many people said we had entered a “new normal”. But as it turns out, the new norm…
18 Aug 2022
A new legal headache for Haleon
Stocks and shares

A new legal headache for Haleon

Haleon, GSK’s former consumer-products arm, spun off last month, has made a dismal debut on the stockmarket.
17 Aug 2022

Most Popular

How to protect your wealth as inflation hits new record highs
Investment strategy

How to protect your wealth as inflation hits new record highs

UK inflation has hit a new record high of 10.1%. It's going to hurt, says Dominic Frisby. Here's how you can protect your wealth.
17 Aug 2022
How to cut your energy bill
Personal finance

How to cut your energy bill

The energy-price cap will almost double in the autumn. What does this mean for your money, and how can you alleviate the squeeze? Ruth Jackson-Kirby h…
17 Aug 2022
Are GSK’s legal troubles a threat to the firm’s survival?
Biotech stocks

Are GSK’s legal troubles a threat to the firm’s survival?

Pharmaceutical giant GlaxoSmithKline is facing legal action over heartburn drug Zantac that has seen billions wiped off its market value. Rupert Hargr…
16 Aug 2022